Noninvasive diagnosis of esophageal varices: Is it feasible?

American Journal of Gastroenterology

Volumn 101, Issue 11, 2006, Pages 2520-2522

  De Franchis, Roberto ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOSCOPY; ESOPHAGUS VARICES; FEASIBILITY STUDY; HUMAN; LIVER CIRRHOSIS; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; REVIEW; SCREENING; SPLEEN EXAMINATION; THROMBOCYTE COUNT;

ESOPHAGEAL AND GASTRIC VARICES; HUMANS; LIVER CIRRHOSIS; PLATELET COUNT; SPLEEN;

EID: 33750523842     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00880.x     Document Type: Review

References (28)

1. Pagliaro L, D'Amico G, Pasta L, et al. Efficacy and efficiency of treatments in portal hypertension. In: de Franchis R, ed. Portal hypertension II, Proceedings of the second Baveno international consensus workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science, 1996:159-79.
2. D'Amico G, de Franchis R, and a cooperative study group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003;38:599-612.
3. Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: A multicenter, cohort study. Am J Gastroenterol 2003;98:653-9.
4. Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004;40:652-9.
5. Di Fiore F, Lecleire S, Merle V, et al. Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: A comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study. Eur J Gastroenterol Hepatol 2005;17:641-7.
6. Christensen E, Fauerholdt L, Schlichting P, et al. Aspects of natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology 1981;81:944-52.
7. D'Amico G, Luca A. Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol 1997;11:243-56.
8. D'Amico G, Pagliaro L, Bosch J. Pharmacologic treatment of portal hypertension: An evidence-based approach. Sem Liver Dis 1999;19:475-505.
9. North-Italian Endoscopic Club for the study and treatment of esophageal varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988;319:983-9.
10. Pascal JP, Calès P, Desmorat H. Natural history of esophageal varices. In: Bosch J, Rodès J, eds. Recent advances in the pathophysiology and treatment of portal hypertension. Serono Symposia review no22. Rome, Italy 1989:127-42.
11. Pagliaro L, D'Amico G, Pasta L, et al. Portal hypertension in cirrhosis: natural history. In: Bosch J, Groszmann RJ, eds. Portal hypertension, pathophysiology and treatment. Oxford: Blackwell Scientific Publications, 1994:72-92.
12. Cottone M, D'Amico G, Maringhini A, et al. Predictive value of ultrasonography in the screening of non-ascitic cirrhotic patients with large varices. J Ultrasound Med 1986;5:189-92.
13. de Franchis R. Updating consensus in portal hypertension: Report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-52.
14. Ng FH, Wong SY, Loo CK, et al. Prediction of oesophagogastric varices in patients with liver cirrhosis. J Gastroenterol Hepatol 1999;14:785-90.
15. Pilette C, Oberti F, Aube C, et al. Non-invasive diagnosis of esophageal varices in chronic liver diseases. J Hepatol 1999;31:867-73.
16. Chalasani N, Imperiale TF, Ismail A, et al. Predictors of large esophageal varices in cirrhosis. Am J Gastroenterol 1999;94:3103-5.
17. Schepis F, Cammà C, Niceforo D, et al. Which patients should undergo endoscopic screening for esophageal varices detection? Hepatology 2001;33:333-8.
18. Zaman A, Becker T, Lapidus J, et al. Risk factors for the presence of varices in cirrhotic patients without history of variceal hemorrhage. Arch Intern Med 2001;161:2564-70.
19. Madhotra R, Mulcahy HE, Willner I, et al. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 2002;34:81-5.
20. Thomopoulos KC, Labropoulou-Karatza C, Mimidis KP, et al. Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Dig Liver Dis 2003;35:473-8.
21. Zein CO, Lindor KD, Angulo P. Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis. Hepatology 2004;39:204-10.
22. Riggio O, Angeloni S, Nicolini G, et al. Endoscopic screening for esophageal varices in cirrhotic patients (letter). Hepatology 2002;35:501-2.
23. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-76.
24. Giannini E, Botta F, Borro P, et al. Platelet count/spleen diameter ratio: Proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003;52:1200-5.
25. Giannini EG, Zaman A, Kreil A, et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: Results of a multicenter, prospective, validation study. Am J Gastroenterol 2006;101:2511-9.
26. Thabut D, Imbert-Bismuth F, Cazals-Hatem D, et al. Diagnostic value of fibrosis biochemical markers (Fibrotest-Fibrosure) for the prediction of severe portal hypertension in patients with and without cirrhosis. Hepatology 2004;40 (suppl 1):202A-3A.
27. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-13.
28. Kazemi F, Kettaneh A, N'Kontchou G, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006;45:230-5.